EQUIVAC T VACCINE

国家: 澳大利亚

语言: 英文

来源: APVMA (Australian Pesticides and Veterinary Medicines Authority)

现在购买

资料单张 资料单张 (PIL)
20-06-2017
产品特点 产品特点 (SPC)
20-06-2017

有效成分:

CLOSTRIDIUM TETANI UF TOXOID; THIOMERSAL

可用日期:

ZOETIS AUSTRALIA PTY LTD

INN(国际名称):

Cl tetani - toxoid

药物剂型:

MISC. VACCINES OR ANTI SERA

组成:

CLOSTRIDIUM TETANI UF TOXOID VACCINE-TOXOID Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml

每包单位数:

10mL Vial; 1mL Syr

类:

VM - Veterinary Medicine

厂商:

ZOETIS AUSTRALIA

治疗组:

CATTLE | DOG | GOAT | HORSE | PIGS | SHEEP | BEEF | BILLY | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUCK | BUFFALO |

治疗领域:

IMMUNOTHERAPY

疗效迹象:

TETANUS | TETANUS VACCINATION

產品總結:

Poison schedule: 0; Withholding period: WHP: Meat:Nil Milk:Nil; Host/pest details: CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; For the immunisation of horses, dogs, cattle, sheep, goats and pigs against tetanus.

授权状态:

Registered

授权日期:

2023-07-01

资料单张

                                AUSTRALIAN GOVERNMENT
Australian Pesticides and
Veterinary Medicines Authority
APPENDIX 2
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS)
(VETERINARY PRODUCTS)
Select appropriate:
13
New Product (include all applicable RLPs) OR
Er Variation (highlight instructions that are being varied). Approval
no. of label being varied: 51772/0306.
Signal heading:
FOR ANIMAL TREATMENT ONLY
Product name:
Equivac® T Vaccine
Active constituent/s:
Equivac T is a purified adjuvanted vaccine containing the formalinised
toxin of
Clostridium
tetani
(20
Lf/mL) The adjuvant, which is an aluminium salt, increases the level
and
duration of the immunity afforded by the vaccine. The type of adjuvant
and the purification
procedures used ensure maximum protection of animals with minimum risk
of local
reactions at the site of injection. Thiomersal 0.1 mg/mL is added as a
preservative.
Statement of claims:
For the immunisation of horses, dogs, cattle, sheep, goats and pigs
against tetanus.
Net contents:
1mL dose syringe.
10mL dose vial.
Directions
for Use
Heading:
"AK\
4,10.
RLP
Approved
DIRECTIONS FOR USE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
Contents must be left in outer package until immediately before use
Shake well before use and keep thoroughly mixed during use
Use all product within 12 hours of opening.
It is important that the vaccine is kept properly mixed before and
during use. There may
be settling of the adjuvant after storage but material is easily
resuspended by inversion of
the syringe or vial.
Before vaccine is injected, the proposed site of inoculation on the
animal's skin may be
cleaned by swabbing with cotton-wool soaked in a suitable antiseptic
solution, such as
methylated spirits.
Restraints:
N/A
Contraindications:
N/A
Precautions:
N/A
Side effects:
Localised swelling may develop at the site of injection and a firm
nodular lump may
persist for some weeks or even months. There may be temporary
lameness. Allergic
reactions such as anaphlylaxis occur rarely with all vaccines and may
require appropriate
treatment
                                
                                阅读完整的文件
                                
                            

产品特点

                                PRODUCT NAME: EQUIVAC
® T VACCINE
PAGE: 1 OF 5
THIS REVISION ISSUED:
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: (02)9850 3333
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: (02) 9850 3333
Fax: (02) 9850 3399
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Saline suspension of vaccine ingredients.
TRADE NAME:
EQUIVAC
® T VACCINE
PFIZER MSDS CODE:
0343
PRODUCT USE:
Vaccine for the prevention of tetanus in horses, dogs, cattle, sheep,
goats and pigs
CREATION DATE:
AUGUST, 2004
THIS VERSION ISSUED:
APRIL 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None allocated. (NZ S2)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Aqueous liquid suspension.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be mil
                                
                                阅读完整的文件